Problem

Finni Health addresses the fragmented, expensive, and difficult-to-access autism-care system, particularly the shortage of high-quality Applied Behavior Analysis (ABA) services. Autism prevalence is high—the CDC reported 32.2 children per 1,000, or one in 31, in its 2025 surveillance—and research has identified too few providers and significant travel barriers. The killer use case is a family whose child needs individualized behavioral support but faces long waits, difficult scheduling, insurance complexity, and limited care available near home.

The problem also exists on the provider side. ABA therapists are constrained by geography, administrative work, insurance contracting, and the capital required to start a practice. Finni frames this as an economic and quality problem: providers want independence and more time with clients, while industry consolidation and more than 200 private-equity-backed M&A deals have raised concerns about incentives and care quality. Finni therefore targets both the family’s access problem and the clinician’s inability to launch a sustainable, independent practice.

Product / Service

Finni is a two-sided, technology-enabled autism-care company. For providers, it supplies a full-stack operating platform covering insurance credentialing and network access, billing and payroll, scheduling, onboarding, compliance, marketing, recruiting, HR, clinical data collection, and client support. The model allows BCBAs and other ABA professionals to launch and run independent practices in weeks rather than months; Finni says providers can get in-network quickly, automate much of intake and eligibility work, and reduce administrative time from roughly 16 hours per week to about four.

For families, Finni matches children with local ABA providers and delivers primarily in-home care, with telehealth also available in some markets. Care begins with intake and assessment, followed by individualized goals, structured one-to-one sessions, positive reinforcement, progress tracking, and parent training. Flexible scheduling, insurance support, and provider-led care are intended to make treatment easier to start and more practical to sustain, while Finni reports improvements in caregiver mental health, family stress, and children’s behavior and development.

Market

Finni competes in the U.S. autism behavioral-health and ABA market, at the intersection of direct care delivery and provider enablement. Its direct-care alternatives include scaled autism therapy networks such as Hopebridge, Cortica, and BlueSprig, while its more structurally similar platform competitors include Alpaca Health, Headstart Health, and Tilly. Finni’s positioning is differentiated from centralized clinic operators by helping independent ABA providers start, operate, and grow their own practices while giving families access to local, insurance-covered care.

Finni is not pre-revenue. Its website currently reports 45 active ABA practices, availability in more than 35 states, and backing from more than 11 major insurers, alongside more than 1,000 families or learners served. Earlier, Y Combinator reported that the company had reached $30,000 in monthly revenue growing 50% month over month seven months after launch, and Finni announced a $3.2 million seed round led by General Catalyst in 2023. The current operating metrics are company-reported rather than independently audited, and no authoritative current revenue figure was established in the available evidence.